Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Institute of Integrative Medicine, Fudan University, Shanghai, China.
Front Immunol. 2022 Jul 11;13:862866. doi: 10.3389/fimmu.2022.862866. eCollection 2022.
CD4 helper T (Th) cell subsets are critically involved in the pathogenesis of asthma. Naive Th cells differentiate into different subsets under the stimulation of different sets of cytokines, and the differentiation process is dominantly driven by lineage specific transcription factors, such as T-bet (Th1), GATA3 (Th2), RORγt (Th17) and Foxp3 (Treg). The differentiation mechanisms driven by these transcription factors are mutually exclusive, resulting in functional inhibition of these Th subsets to each other, particularly prominent between effector Th cells and Treg cells, such as Th2 versus Treg cells and Th17 versus Treg cells. Being of significance in maintaining immune homeostasis, the balance between effector Th cell response and Treg cell immunosuppression provides an immunological theoretical basis for us to understand the immunopathological mechanism and develop the therapy strategies of asthma. However, recent studies have found that certain factors involved in effector Th cells response, such as cytokines and master transcription factors (IL-12 and T-bet of Th1, IL-4 and GATA3 of Th2, IL-6 and RORγt of Th17), not only contribute to immune response of effector Th cells, but also promote the development and function of Treg cells, therefore bridging the interplay between effector Th cell immune responses and Treg cell immunosuppression. Although we have an abundant knowledge concerning the role of these cytokines and transcription factors in effector Th cell responses, our understanding on their role in Treg cell development and function is scattered thus need to be summarized. This review summarized the role of these cytokines and transcription factors involved in effector Th cell responses in the development and function of Treg cells, in the hope of providing new insights of understanding the immunopathological mechanism and seeking potential therapy strategies of asthma.
CD4+辅助性 T(Th)细胞亚群在哮喘发病机制中起着至关重要的作用。幼稚 Th 细胞在不同细胞因子的刺激下分化为不同的亚群,分化过程主要由谱系特异性转录因子驱动,如 T 细胞特异性转录因子(T-bet)(Th1)、GATA 结合蛋白 3(GATA3)(Th2)、维甲酸相关孤核受体γt(RORγt)(Th17)和叉头框蛋白 P3(Foxp3)(Treg)。这些转录因子驱动的分化机制相互排斥,导致这些 Th 亚群之间的功能抑制,特别是在效应 Th 细胞和 Treg 细胞之间,如 Th2 与 Treg 细胞和 Th17 与 Treg 细胞之间。这些转录因子在维持免疫稳态方面具有重要意义,效应 Th 细胞反应和 Treg 细胞免疫抑制之间的平衡为我们理解哮喘的免疫病理机制和开发治疗策略提供了免疫学理论基础。然而,最近的研究发现,参与效应 Th 细胞反应的某些因素,如细胞因子和主转录因子(Th1 中的白细胞介素 12 和 T-bet、Th2 中的白细胞介素 4 和 GATA3、Th17 中的白细胞介素 6 和 RORγt),不仅有助于效应 Th 细胞的免疫反应,而且促进了 Treg 细胞的发育和功能,从而连接了效应 Th 细胞免疫反应和 Treg 细胞免疫抑制之间的相互作用。尽管我们对这些细胞因子和转录因子在效应 Th 细胞反应中的作用有了丰富的认识,但我们对它们在 Treg 细胞发育和功能中的作用的认识是分散的,因此需要进行总结。本综述总结了这些参与效应 Th 细胞反应的细胞因子和转录因子在 Treg 细胞发育和功能中的作用,以期为理解哮喘的免疫病理机制和寻求潜在的治疗策略提供新的见解。